NewsConcerns explains that Molnupiravir, Merck’s new anti-viral, has issues with both efficacy and safety.
FLCCC founder and Chief Medical Officer, Dr. Pierre Kory, talked to Eric Bolling on The Balance and compared Merck's "COVID pill" to ivermectin.
Contact Us
Mailing Address
FLCCC Alliance
2001 L St. NW Suite 500
Washington, DC 20036
Media
Clinical Support
General
Shortcuts
Follow Us
Contact Us
Mailing Address
FLCCC Alliance
2001 L St. NW Suite 500
Washington, DC 20036
Media
Clinical Support
General
Shortcuts
Support Us
Follow Us
Disclaimer
©2020–2023 All Rights Reserved FLCCC Alliance. The information contained or presented on this website is for educational purposes only. Information on this site is NOT intended to serve as a substitute for diagnosis, treatment, or advice from a qualified, licensed medical professional. The facts presented are offered as information only in order to empower you – our protocol is not medical advice – and in no way should anyone infer that we, even though we are physicians, or anyone appearing in any content on this website are practicing medicine, it is for educational purposes only. Any treatment protocol you undertake should be discussed with your physician or other licensed medical professional. Seek the advice of a medical professional for proper application of ANY material on this site or our program to your specific situation. NEVER stop or change your medications without consulting your physician. If you are having an emergency contact your emergency services: in the USA that’s 911. Please read our complete disclaimers.
© Copyright 2023. FLCCC Alliance. All Rights Reserved.